西洛多辛
Silodosin
西洛多辛;西洛多辛及中间体;西罗多辛-D4;西洛多辛(标准品);西洛多辛杂质;2,3-二氢-1-(3-羟丙基)-5-[(2R)-2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙胺基]丙基]-1H-吲哚-7-甲酰胺;2,3-二氢-1-(3-羟基丙基)-5-[(2R)-2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙胺基]丙基]-1H-吲哚-7-甲酰胺;西罗多辛;赛洛多辛;西洛多辛 西罗多辛;西洛多辛(R);西洛多辛(R-异构体);西洛多辛标准品;西洛多辛异构体;西洛多辛A;西洛多辛, 一种Α1-肾上腺素受体拮抗剂;赛洛多辛杂质;西洛多辛原料药;西洛多辛(R);西洛多辛(R) 西洛多辛;西洛多辛及中间体;西罗多辛-D4;西洛多辛(标准品);西洛多辛杂质;2,3-二氢-1-(3-羟丙基)-5-[(2R)-2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙胺基]丙基]-1H-吲哚-7-甲酰胺;2,3-二氢-1-(3-羟基丙基)-5-[(2R)-2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙胺基]丙基]-1H-吲哚-7-甲酰胺;西罗多辛;赛洛多辛;西洛多辛 西罗多辛;西洛多辛(R);西洛多辛(R-异构体);西洛多辛标准品;西洛多辛异构体;西洛多辛A;西洛多辛, 一种Α1-肾上腺素受体拮抗剂;赛洛多辛杂质;西洛多辛原料药;西洛多辛(R);西洛多辛(R) 展开
160970-54-7
C25H32F3N3O4
495.53
中文名称 西洛多辛
中文别名 西洛多辛;西洛多辛及中间体;西罗多辛-D4;西洛多辛(标准品);西洛多辛杂质;2,3-二氢-1-(3-羟丙基)-5-[(2R)-2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙胺基]丙基]-1H-吲哚-7-甲酰胺;2,3-二氢-1-(3-羟基丙基)-5-[(2R)-2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙胺基]丙基]-1H-吲哚-7-甲酰胺;西罗多辛;赛洛多辛;西洛多辛 西罗多辛;西洛多辛(R);西洛多辛(R-异构体);西洛多辛标准品;西洛多辛异构体;西洛多辛A;西洛多辛, 一种Α1-肾上腺素受体拮抗剂;赛洛多辛杂质;西洛多辛原料药;西洛多辛(R);西洛多辛(R)
英文名称 Silodosin
英文别名 Silodosin;Silodosin-d4;Silodoxin;1H-Indole-7-carboxaMide,2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]aMino]propyl]-;1-(3-hydroxypropyl)-5-[(2R)-({2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}aMino)propyl]indoline-7-carboxaMide;(–)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide;KAD 3213;KMD 3213;(R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide;1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide;2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-Indole-7-carboxamide;[14C]-Silodosin;[3H]-Silodosin;1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide;KMD-3213;Rapaflo;Silodyx;UNII-CUZ39LUY82;Urief;1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2­trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide;Rapallo;1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide;[ "" ];Silodosin API;Silodosin(Rapaflo);Urorec;CUZ39LUY82;Silodosin-d6;Rapflo;1H-Indole-7-carboxamide, 2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]e;Q411770;HY-10122;BDBM50160154;DTXSID40167045;1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide;DB06207;(R)-5-[2-[[2-[2-(2,2,2-trifluoro-ethoxy)phenoxy]ethyl]amino]propyl]-1-(3-hydroxypropyl)-2,3-dihydro-1H-indole-7-carboxamide;CHEMBL24778;Silodosin, >=98% (HPLC);CS-0284;KAD-3213;1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]-ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide;SMR004701206;NCGC00345882-03;SILODOSIN [EMA EPAR];SILODOSIN [JAN];SR-01000944157-1;(r)-1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide;(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide;CCG-221202;SILODOSIN [WHO-DD];SR-01000944157;SCHEMBL136973;AC-22605;HMS3884O21;Silodosina;KAD 3213;KMD 3213;SW219765-1;SILODOSIN [MI];CHEBI:135929;DTXCID3089536;2,3-DIHYDRO-1-(3-HYDROXYPROPYL)-5-((2R)-2-((2-(2-(2,2,2-TRIFLUOROETHOXY)PHENOXY)ETHYL)AMINO)PROPYL)-1H-INDOLE-7-CARBOXAMIDE;1-(3-Hydroxypropyl)-5-((2R)-2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide;EN300-6481367;( C)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide;1-(3-Hydroxy-propyl)-5-((R)-2-{2-[2-(2,2,2-trifluoro-ethoxy)-phenoxy]-ethylamino}-propyl)-2,3-dihydro-1H-indole-7-carboxylic acid amide;...
CAS No. 160970-54-7
分子式 C25H32F3N3O4
分子量 495.53
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS